This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xope4 [2020/07/08 17:52] – [XopE4] rkoebnik | bacteria:t3e:xope4 [2025/07/24 22:28] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== XopE4 ====== | + | ====== |
| Author: [[https:// | Author: [[https:// | ||
| Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
| - | Expert reviewer: | + | Expert reviewer: |
| Class: XopE\\ | Class: XopE\\ | ||
| Family: XopE4\\ | Family: XopE4\\ | ||
| Prototype: XAUC_31730 (// | Prototype: XAUC_31730 (// | ||
| - | Protein Accession | + | GenBank |
| + | RefSeq ID: [[https:// | ||
| 3D structure: unknown | 3D structure: unknown | ||
| Line 16: | Line 17: | ||
| XopE4 was first identified by sequence homology searches (Moreira //et al//., 2010). | XopE4 was first identified by sequence homology searches (Moreira //et al//., 2010). | ||
| + | |||
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| Line 27: | Line 29: | ||
| The gene sequence of xopE4 is similar to XopE2 (avrXacE3), but due to its low amino acid sequence identity (31%) was considered a different effector that can discriminate between X. citri and //X. fuscans// pv. aurantifolii strains, both causing citrus bacterial canker (Moreira //et al//., 2010; Dalio //et al//., 2017). Disease symptoms caused by // | The gene sequence of xopE4 is similar to XopE2 (avrXacE3), but due to its low amino acid sequence identity (31%) was considered a different effector that can discriminate between X. citri and //X. fuscans// pv. aurantifolii strains, both causing citrus bacterial canker (Moreira //et al//., 2010; Dalio //et al//., 2017). Disease symptoms caused by // | ||
| + | |||
| === Localization === | === Localization === | ||
| As XopE4 does not have a predicted myristoylation site, suggesting that it may not be targeted to the cell membrane as the other XopE family member (Moreira //et al//., 2010). | As XopE4 does not have a predicted myristoylation site, suggesting that it may not be targeted to the cell membrane as the other XopE family member (Moreira //et al//., 2010). | ||
| + | |||
| === Enzymatic function === | === Enzymatic function === | ||
| XopE4 belongs to the HopX effector family, which are part of the transglutaminase superfamily (Nichmuk //et al//., 2007). | XopE4 belongs to the HopX effector family, which are part of the transglutaminase superfamily (Nichmuk //et al//., 2007). | ||
| + | |||
| === Interaction partners === | === Interaction partners === | ||
| Line 42: | Line 47: | ||
| Yes (//e.g.//, //X. axonopodis// | Yes (//e.g.//, //X. axonopodis// | ||
| + | |||
| + | XopE4 is also present in //X. fragariae// (Vandroemme //et al//., 2013) and it is not very conserved among //X. perforans// strains (Schwartz //et al//., 2015). | ||
| === In other plant pathogens/ | === In other plant pathogens/ | ||
| Line 55: | Line 62: | ||
| Nimchuk ZL, Fisher EJ, Desvaux D, Chang JH, Dangl JL (2007). The HopX (AvrPphE) family of // | Nimchuk ZL, Fisher EJ, Desvaux D, Chang JH, Dangl JL (2007). The HopX (AvrPphE) family of // | ||
| + | |||
| + | Schwartz, A. R., Potnis, N., Timilsina, S., Wilson, M., Patané, J., Martins Jr, J., & Vallad, G. E. (2015). Phylogenomics of // | ||
| + | |||
| + | Vandroemme, J., Cottyn, B., Baeyen, S., De Vos, P., & Maes, M. (2013). Draft genome sequence of // | ||
| + | |||
| + | ===== Acknowledgements ===== | ||
| + | |||
| + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||